MARISSA FELASCO: Open Payments
NPI 1164175618 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,264 in 196 payments from 18 companies in 2025. Trend: 2023 $3,936 · 2024 $4,472 · 2025 $3,264
Food & beverage: $3,264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $588 |
| Novartis Pharmaceuticals Corporation | 33 | $427 |
| Regeneron Healthcare Solutions, Inc. | 11 | $348 |
| UCB, Inc. | 26 | $332 |
| Janssen Biotech, Inc. | 19 | $330 |
| LEO Pharma Inc. | 10 | $255 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $225 |
| Amgen Inc. | 12 | $174 |
| Lilly USA, LLC | 8 | $162 |
| GENZYME CORPORATION | 3 | $127 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, COSENTYX, ADBRY, ILUMYA, OTEZLA.
Industry payments across NY — which companies pay providers there.
